Rennova Health Stock Price, News & Analysis (OTCMKTS:RNVA)

$0.08 -0.01 (-11.11 %)
(As of 12/12/2017 05:09 AM ET)
Previous Close$0.09
Today's Range$0.08 - $0.10
52-Week Range$0.06 - $103.50
Volume574,527 shs
Average Volume490,125 shs
Market Capitalization$500,000.00
P/E RatioN/A
Dividend YieldN/A

About Rennova Health (OTCMKTS:RNVA)

Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova's principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.

Receive RNVA News and Ratings via Email

Sign-up to receive the latest news and ratings for RNVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Enterprise Software


Debt-to-Equity Ratio-0.26%
Current Ratio0.11%
Quick Ratio0.10%


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.24 million
Price / Sales0.09
Cash FlowN/A
Price / CashN/A
Book Value($79.74) per share
Price / Book0.00


Trailing EPSN/A
Net Income$-32,610,000.00
Net Margins-1,918.71%
Return on EquityN/A
Return on Assets-1,232.10%


Outstanding Shares5,640,000

Rennova Health (OTCMKTS:RNVA) Frequently Asked Questions

What is Rennova Health's stock symbol?

Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."

When did Rennova Health's stock split? How did Rennova Health's stock split work?

Rennova Health shares reverse split before market open on Friday, October 6th 2017. The 1-15 reverse split was announced on Friday, September 22nd 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 7 shares after the split.

How were Rennova Health's earnings last quarter?

Rennova Health, Inc. (OTCMKTS:RNVA) announced its quarterly earnings data on Monday, November, 20th. The company reported ($10.59) earnings per share for the quarter. The business earned $1.41 million during the quarter. View Rennova Health's Earnings History.

Who are some of Rennova Health's key competitors?

Who are Rennova Health's key executives?

Rennova Health's management team includes the folowing people:

  • Seamus Lagan, President, Chief Executive Officer, Interim Chief Financial Officer, Director (Age 48)
  • John B. Beach, Director (Age 55)
  • Paul R. Billings M.D. Ph.D., Director (Age 63)
  • Christopher E. Diamantis, Director (Age 48)
  • James M. Karis, Director (Age 66)
  • Robert P. Lee, Director (Age 62)

How do I buy Rennova Health stock?

Shares of Rennova Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rennova Health's stock price today?

One share of Rennova Health stock can currently be purchased for approximately $0.08.

How big of a company is Rennova Health?

Rennova Health has a market capitalization of $500,000.00 and generates $5.24 million in revenue each year. Rennova Health employs 116 workers across the globe.

How can I contact Rennova Health?

Rennova Health's mailing address is 400 S. Australian Avenue 8th Floor, West Palm Beach FL, 33401. The company can be reached via phone at 561-855-1626 or via email at [email protected]

MarketBeat Community Rating for Rennova Health (RNVA)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  74
MarketBeat's community ratings are surveys of what our community members think about Rennova Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Rennova Health (OTCMKTS:RNVA) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Rennova Health (OTCMKTS:RNVA) Earnings History and Estimates Chart

Earnings by Quarter for Rennova Health (OTCMKTS:RNVA)

Rennova Health (OTCMKTS RNVA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/20/2017Q3 2017($10.59)$1.41 millionViewN/AView Earnings Details
8/15/2017Q2 2017($20.55)$0.90 millionViewN/AView Earnings Details
11/14/2016Q316($15.00)($4.35)$5.89 million$0.29 millionViewN/AView Earnings Details
5/16/2016Q116($2.10)$1.88 millionViewN/AView Earnings Details
2/13/2015($5.55)($5.70)ViewN/AView Earnings Details
11/13/2014($7.35)($5.25)$0.11 million$0.18 millionViewN/AView Earnings Details
8/14/2014Q214($7.35)($9.15)$0.06 million$0.06 millionViewN/AView Earnings Details
2/11/2014($7.35)($7.20)$0.06 millionViewN/AView Earnings Details
11/13/2013Q2($4.35)ViewN/AView Earnings Details
11/14/2012Q213($10.20)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Rennova Health (OTCMKTS:RNVA) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Rennova Health (OTCMKTS:RNVA)

No dividend announcements for this company have been tracked by

Insider Trades

Rennova Health (OTCMKTS RNVA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 19.29%
Insider Trades by Quarter for Rennova Health (OTCMKTS:RNVA)

Rennova Health (OTCMKTS RNVA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/14/2016Jason AdamsCFOBuy1,160$0.28$324.80View SEC Filing  
7/14/2016Michael Louis GoldbergDirectorBuy2,500$0.28$700.00View SEC Filing  
7/14/2016Seamus LaganCEOBuy10,900$0.38$4,142.00View SEC Filing  
6/7/2016Jason AdamsCFOBuy270$0.75$202.50View SEC Filing  
6/3/2016Jason AdamsCFOBuy295$0.63$185.85View SEC Filing  
5/23/2016Michael Louis GoldbergDirectorBuy1,500$0.61$915.00View SEC Filing  
11/15/2013Carl MuscariDirectorBuy1,300$3.85$5,005.00View SEC Filing  
3/26/2013Carl MuscariDirectorBuy1,540$3.25$5,005.00View SEC Filing  
10/5/2012Participations Alcatel-LucentMajor ShareholderSell149,200$4.20$626,640.00View SEC Filing  
(Data available from 1/1/2013 forward)


Rennova Health (OTCMKTS RNVA) News Headlines


SEC Filings

Rennova Health (OTCMKTS:RNVA) SEC Filings

DateFilerForm TypeView

Social Media


Rennova Health (OTCMKTS:RNVA) Income Statement, Balance Sheet and Cash Flow Statement


Rennova Health (OTCMKTS RNVA) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.